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Background: For early prediction of upper extremity function, there is a need for short clinical measurements
suitable for acute settings. Previous studies demonstrate correct prediction of function, but have ether included a
complex assessment procedure or have an outcome that does not automatically correspond to motor function
required to be useful in daily activity. The purpose of this study was to investigate whether a sub-set of items from
the Action Research Arm Test (ARAT) at 3 days and 1 month post-stroke could predict the level of upper extremity
motor function required for a drinking task at three later stages during the first year post-stroke.
Methods: The level of motor function required for a drinking task was identified with the Fugl-Meyer Assessment
for Upper Extremity (FMA-UE). A structured process was used to select ARAT items not requiring special equipment
and to find a cut-off level of the items’ sum score. The early prognostic values of the selected items, aimed to
determine the level of motor function required for a drinking task at 10 days and 1 and 12 months, were investigated
in a cohort of 112 patients. The patients had a first time stroke and impaired upper extremity function at day 3 after
stroke onset, were ≥18 years and received care in a stroke unit.
Results: Two items, “Pour water from glass to glass” and “Place hand on top of head”, called ARAT-2, met the
requirements to predict upper extremity motor function. ARAT-2 is a sum score (0-6) with a cut-off at 2 points,
where >2 is considered an improvement. At the different time points, the sensitivity varied between 98 % and 100 %,
specificity between 73 % and 94 %. Correctly classified patients varied between 81 % and 96 %.
Conclusions: Using ARAT-2, 3 days post-stroke could predict the level of motor function (assessed with FMA-UE)
required for a drinking task during the first year after a stroke. ARAT-2 demonstrates high predictive values, is easily
performed and has the potential to be clinically feasible.
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Each patient’s specific needs should be identified early
after a stroke in order to reduce impairment, optimize
rehabilitation and minimize costs. A common impair-
ment after stroke is reduced upper extremity (UE)
function which renders an increased risk of dependency
on others and a prolonged in-patient stay [1]. Greater
knowledge about the results of reduced UE after a
stroke has been emphasized by patients as important
[2], but the evaluation of UE functioning requires staff,
equipment and time, which increases costs. Clinical
scales, such as the Fugl-Meyer Assessment [3] and the
Action Research Arm Test (ARAT) [4–6] are available
for assessment of functioning in the UEs after stroke.
Comprehensive clinical assessments can be time con-
suming or require special equipment, and might there-
fore be less suitable for screening in the acute setting.
Important factors predicting UE recovery after a stroke
are initial motor function, stroke severity, and initial
neuropsychological status [7–9]. Previous studies demon-
strate that the presence of finger extension and shoulder
abduction early post-stroke predicts UE functioning at six
months [10–12]. A combination of the clinical assessment
and transcranial magnetic stimulation (TMS) or magnetic
resonance imaging (MRI) has also been shown to have
high prediction accuracy at 12 weeks after stroke onset
[13]. However, in these studies the assessment procedures
are complex, or the outcome does not tell us if this pre-
dicted motor function can be useful for daily activities. A
quickly administered clinical test predicting meaningful
recovery of function, reflecting the patient’s ability to use
their affected arm in a daily activity, would be warranted
for efficient treatment planning.
The purpose of this study was to investigate whether a
sub-set of items from ARAT, administered at 3 days and
1 month post-stroke, could predict the level of UE
motor function (assessed with the FMA-UE) required




Over a period of 18 months in 2009-2010, 117 patients
from a stroke unit at the Sahlgrenska University Hospital
in Gothenburg, Sweden, were consecutively included in
the Stroke Arm Longitudinal Study at the University of
Gothenburg (SALGOT study) [14], ClinicalTrials.gov:
NCT01115348. The SALGOT study had the following
inclusion criteria: 1) first clinical stroke (ischaemic or
haemorrhagic), diagnosed according to the World Health
Organization; 2) impaired UE function at day 3 (±1 day)
after stroke onset, defined as <57 points on ARAT (0-57
points) [4, 6]; 3) receiving treatment in the stroke unit at
3 days after onset; 4) residency in the Gothenburg urbanarea; and 5) ≥18 years of age. The exclusion criteria were:
1) an UE injury/condition prior to the stroke that limited
the functional use of the affected arm and hand; 2) severe
multi-impairment or diminished physical condition before
the stroke; 3) short life expectancy; and 4) non-Swedish
speaking. In addition, in the present study, a 5th exclusion
criterion was used: 66 points on the Fugl-Meyer Assess-
ment scale for Upper Extremity (FMA-UE) [3] (0-66
points) at 3 days post stroke. These criteria resulted in a
cohort of 112 eligible patients. The SALGOT study re-
ceived ethical approval from the Regional Ethical Review
Board in Gothenburg. All patients, or their next of kin,
provided written informed consent for participation.
Clinical assessments and procedures
UE motor function at 3 days after stroke onset was
assessed with the FMA-UE, [3, 15] consisting of 33
items, each scored 0-2 and summed to a total score of
0-66 points. The total score on the FMA-UE was strati-
fied into two groups: severe UE impairment (≤31) and
mild/moderate UE impairment (≥32). A score of FMA-
UE ≥32 was used to identify patients from the SALGOT
cohort who possessed the motor function required for a
drinking task with the paretic arm and used as the cut-
off between the two groups. This cut-off was based on a
previous study [16], in which patients were included if
they were able to perform a drinking task with their af-
fected arm (lowest score for FMA-UE was 32 points).
This drinking task requires the capacity to reach, grasp,
lift, transport the glass as well as drink. Validation of the
cut-off score of FMA-UE ≥32 to correctly classify pa-
tients’ motor ability to drink from a glass (the drinking
task) was based on the entire cohort. The results were:
at 10 days sensitivity 98 % (CI 95 % 0.91-1.0) and specificity
89 % (0.77-0.96), at 1 month sensitivity 100 % (0.92-1.0)
and specificity 93 % (0.84-0.98) and at 12 months sensitiv-
ity 100 % (0.85-1.0) and specificity 96 % (0.87-1.0). These
results confirmed the use of this cut-off in the subsequent
analysis. The majority of classification errors occurred in
data gathered at 10 days post stroke, on the group of
patients with moderate/mild UE impairment but with a
poor hand function and inability to grip and perform the
drinking task (n = 6).
Three physiotherapists, after joint training, performed
the clinical assessments according to a standardized pro-
cedure [14]. The majority of the assessments were per-
formed at the hospital, and if the patient was unable to
travel, assessment was conducted in the patient’s home,
nursing home or rehabilitations unit. Global neurological
deficits were detected by physicians using the National
Institute of Health Stroke Scale, NIHSS (0 = no deficit,
42 = severe neurologic deficit) at arrival [17]. Type of is-
chemic stroke was classified according to the Bamford
classification [18]. The assessment procedure is shown
Fig. 1 Flowchart of the assessments and the drop-outs at different time points
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functional task-specific rehabilitation from the first day
at the stroke unit. Physiotherapist and occupational ther-
apist were available in the primary care system as well as
in the community and in nursing homes. The level of
rehabilitation received at the different test occasions
during the first year is described in Table 1, and follows
the Swedish national guidelines [19].
ARAT and reduction of items
The ARAT [4–6] consists of 19 items, and the perform-
ance of each item is scored on a 4-point ordinal scale
ranging from 0 (no task performance) to 3 (normal task
performance) and summed to a total score of 0-57. The
ARAT was performed in a standardized manner [6, 20]
at 3 days and 1 month post-stroke. These time-points
were considered as being of possible clinical importance
for both early and long term rehabilitation planning.
The procedure for choosing a sub-set of items from the
ARAT was conducted in four steps (Fig. 2): 1) items not
requiring special equipment were identified (consensus
among the authors and physiotherapists at the stroke
unit); 2) the minimum number of items needed to capture
most of the variance in the ARAT at day 3 was explored;
3) according to published results of a Mokken scale ana-
lysis [21], items identified by their means as highest or
lowest in degree of difficulty were excluded; and 4) from
the same analysis [21] the two remaining items with the
greatest distance in their means were selected, in order to
identify UE function at various degrees of stroke severity.
From the selected sub-set of ARAT items, a cut-off level
with potential to be clinically useful was determined where
a higher score indicates better function.
The selected ARAT items from 3 days post stroke were
used to predict the UE function (to detect the motorfunction required for a drinking task using the paretic
arm) at 10 days, 1 month and 12 months post stroke; and
the ARAT items from 1 month post stroke were used to
predict the UE function at 12 months post stroke.
Data handling and statistics
To enable the use of data from 18 patients not assessed at
day 10 using the FMA-UE (due to administrative prob-
lems), an estimated score for each patient was obtained in
the following manner: The mean change from day 3 to
day 10 for all patients assessed at both time points (n = 94)
was calculated and added to each of the 18 patients’ day 3
FMA-UE scores. An estimated value at day 10 could not
exceed the score of the subsequent assessment.
Age differences between the groups were analysed
with an independent t-test, categorical variables with
Mann–Whitney U test and dichotomized variables with
Fisher’s exact test. Correlations between all of the ARAT
variables were investigated with Spearman’s rank correl-
ation (rho). The fewest number of items needed was
verified using principal components analysis (PCA)
based on the total population (n = 117). Only compo-
nents with eigenvalues ≥1 were selected and items with
loading values greater than 0.6 were considered, accord-
ing to Kaiser’s criterion [22]. Using receiver operation
characteristic (ROC) curves, an optimal cut-off level of
the score of the sub-set of ARAT items for all time
points was identified. The maximum sensitivity and spe-
cificity levels were estimated with preference given to
the sensitivity. The score of the sub-set of ARAT items
was analyzed with 2-way contingency tables at day 10,
month 1 and month 12. The sensitivity, specificity, posi-
tive predicted value (PPV), negative predicted value
(NPV), percentage of correctly classified patients, and
likelihood ratios were calculated at each time point,
Table 1 Characteristics at day 3 post-stroke, presented for the





Number of patients, n (%) 112 (100) 62 (55) 50 (45)
Age, years, mean (SD) 69 (13.0) 71 (12.3) 67 (13.6)
Men, % 55 53 58
Independence in mobility pre-stroke, % 94 92 96
Location of stroke, %
Right 52 56 48
Left 42 42 42
Bilateral 4 0 2
Brain stem 1 0 1
Unknown 1 2 0
Ischaemic stroke, % 83 79 88
Intracerebral haemorrhage, % 17 21 12
Type of ischaemic stroke, Bamford, %
Total anterior cerebral infarct 16 27 5
Lacunar anterior cerebral infarct 34 16 55
Partial anterior cerebral infarct 43 53 35
Posterior circulation infarct 7 4 9
Treated with thrombolysis, % 12 15 8
Treated with thrombectomy, % 4 5 2
Stroke Severity, NIHSS (0-42 p)
median, (q1-q3) 7 (3-13) 12 (8-17) 4 (3-6)
Dominant arm affected, % 45 43 46
UE functioning day 3, FMA-UE (0-66 p)
median, (q1-q3) 18 (4-55) 4 (2-10) 56 (47-61)
UE functioning day 3, ARAT (0-57 p)
median, (q1-q3)
4.5 (0-43) 0 (0-3) 46 (35-51)
Obtained rehaba, %
Day 3, inpatient rehab, n = 112 100 100 100
Day 10, rehab/no rehab, n = 112 93/ 7 98/2 82/18
1 Month, rehab/no rehab, n = 104 82/ 18 97/ 3 63/37
12 Month, rehab/no rehab, n = 74 38/62 59/41 16/84
aObtained PT and/or OT intervention
Abbreviation: ARAT, The Action Research Arm Test; Bamford classification; FMA-UE,
the Fugl-Meyer Assessment Scale for Upper Extremity; NIHSS, National Institutes
of Health Stroke Scale; OT, Occupational therapist; Rehab, Rehabilitation; PT,
Physiotherapist; q1-q3 1st and 3rd quartile values; UE, upper extremity
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To provide strong evidence in most circumstances (in a
stroke population) positive likelihood ratio values should
be above 10 and negative likelihood ratios should be
below 0.1 [25]. The statistical analysis was conducted
using IBM Statistical Package for Social Sciences (SPSS
version 21.0) for Windows, and the CI of likelihood ra-
tios were calculated using the Prop CIs Package in R ver-
sion 3.1.1 (2014-07-10).Results
In total, all 112 patients were assessed at days 3 and 10, 9
patients (8 %) were lost to follow-up at 1 month, and 39
patients (35 %) were lost to follow-up at 12 months (Fig. 1).
There were no significant differences between the sex
of the participants, initial stroke severity or initial UE
function when comparing patients who completed the
study (n = 73) and those who dropped out at 12 months
(n = 39); however, the drop-outs were, on average, 6.6 years
older, (p = 0.017). The clinical characteristics of the 112
patients are presented for the whole group and for the two
subgroups (FMA-UE cut off ≥32 points) in Table 1.
The correlations between the ARAT items varied be-
tween rho 0.736 and 0.981. The PCA of the ARAT iden-
tified one factor (dimension) with two components with
eigenvalues ≥1, which together explained 95.1 % of the
total variance. Furthermore, the PCA showed that all of
the items had a component value >0.875, indicating that
any of the items could be used in a sub-set. Following the
criteria of the selection process as shown in Fig. 2, the final
two remaining items were “Pour water from glass to glass”
and “Place hand on top of head”, which comprised the
ARAT-2. The ARAT-2 score was composed as the sum
score of the two original items (0-6). Figure 3 shows the
predictive value of the ARAT-2 to classify the motor func-
tion required for a drinking task (FMA-UE ≥32 points)
and a cut-off level of 2 points on the ARAT-2 was identi-
fied as appropriate to predict outcomes at day 10, month
1 and month 12. The greatest area under the curve was
observed from day 3 to day 10: 0.99 (Fig. 3, a).
Correctly classified patients, identified by 2-way con-
tingency tables using the ARAT-2 from day 3 to day 10,
was 96 % (CI 95 % 0.91-0.99), at 1 month 87 %, (CI 95 %
0.80-0.93), and at 12 months 81 % (CI 95 % 0.70-0.89).
Using the ARAT-2 from 1 month, correctly classified pa-
tients at 12 months was 92 % (CI 95 % 0.83-0.97). Table 2
shows the sensitivity, specificity, and predictive values of
the ARAT-2 for each time point. In summary, the pre-
dictive values of the ARAT-2 to correctly classify patents
level of UE motor function required for a drinking task
were shown to be highest from day 3 to day 10. Further-
more, the ARAT-2 had high sensitivity and NPV and
negative likelihood ratios at every time point, indicating
a high probability to accurately predict motor function
required for the drinking task in patients who initially
had >2 points on ARAT-2. Lower specificity and PPV
and positive likelihood ratios were observed from day 3
to 1 month and from day 3 to 12 months.
Discussion
Information from a sub-set of two items from ARAT
used at 3 days post-stroke showed a high ability to cor-
rectly predict the level of motor function needed for a
common daily task at 10 days, 1 and 12 months after
Fig. 2 Illustration of the selection process to identify items from the Action Research Arm Test (ARAT) feasible for clinical use in the acute stage
to predict the motor function required for a drinking task (FMA-UE ≥32 points), within the first year after stroke
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feasible, were “Pour water from glass to glass” and “Place
hand on top of the head”, named ARAT-2. Based on as-
sessment at 3 days post-stroke the ARAT-2 was shown
to have very high NPVs (95-100 %) at 10 days, 1 and
12 months, indicating accurate prediction of patients
having some arm and hand function (ARAT-2 > 2) at an
early stage. The PPVs during the first year indicated less
accurate prediction in patients with no or very little arm
and hand function (ARAT-2 ≤ 1) at day 3. The difficulty
to correctly predict UE motor function in patients with
initially low function has previously been shown [13, 26].
One possible reason for this limitation may be the stroke
severity itself and that restitution of motor function, as
well as rehabilitation with sufficient intensity starts later
for these patients [27]. Another explanation could be
that the clinical assessment scores at stroke onset does
not give enough information to distinguish between pa-
tients with similar initial impairment but with different
recovery potential and thereby predicted outcomes [13].
To perform the items in ARAT-2, some initial function
in shoulder abduction, flexion, elevation and finger ex-
tension is required. The item in ARAT, “Pour water
from glass to glass”, consists of a similar movement as
when drinking, but to receive one point the patient only
needs to initiate the task. Initial function in shoulder ab-
duction and finger extension has been described as im-
portant predictors for outcomes in UE function at
6 months [10, 12]. One of these studies [10] based onpatients with anterior circulation stroke, used a cut-off
level ≤10 on the ARAT which does not automatically re-
flect recovery of function or ability meaningful for use of
the arm in an activity [28]. It is not clear if that cut-off
provides sufficient information to guide clinical deci-
sions about the predicted ability to use an upper extrem-
ity in an activity [29]. When combining the clinical
assessment with TMS or MRI using an algorithm [13],
the accurate prediction of motor function increased, par-
ticularly in patients with low function initially, but this
would also increase the cost and would not be feasible
in all stroke units or hospitals. A complex algorithm
could also be a barrier to applying prognostic models in
routine care [30]. A recently published review [31] on
prediction of motor recovery summarizes the overall
prediction accuracy of outcome in 3 different recovery
levels on ARAT at 6 months post stroke and compares 3
different approaches of correct prediction. Two gave less
correct prediction compared to the approach in the
present study; one with a competent prediction of expe-
rienced therapists and another using clinical assessment
(finger extension and shoulder abduction), assessed
within 72 h or at discharge. The third approach with a
combination of clinical assessment and TMS or MRI
evaluation, using an algorithm [13] yielded sufficient in-
formation to predict 82 % accurately. In the present
study using ARAT-2, very high overall correct classifica-
tion ability (81 %) from day 3 to 12 months was shown
using only two items. The new ARAT-2 does not cover
A B
DC
Fig. 3 Illustration of the properties of the two item “Pour water from glass to glass” and “Place hand on top of head” (sum score 0-6 points) from the
Action Research Arm Test (ARAT), to predict the patient’s ability to have the motor function required to use the paretic arm in a drinking task (FMA-UE
≥32 points), using receiver operating characteristic (ROC) curves. The optimal cut-off level at 2 points in the different assessments (A-D) is presented.
A) the assessment at day 3 predicting day 10, B) the assessment at day 3 predicting month 1, C) the assessment at day 3 predicting month 12, D) the
assessment at month 1 predicting month 12. Abbreviation: ACU, area under the curve
Table 2 Sensitivity, specificity, predictive values, and likelihood ratios for ARAT-2 at the different assessments
Day 3-10 days (CI) Day 3-1 Month (CI) Day 3-12 Months (CI) 1-12 Months (CI)
Sensitivity 0.98 (0.91-1.0) 1.00 (0.92-1.0) 1.00 (0.85-1.0) 1.00 (0.85-1.0)
Specificity 0.94 (0.84-0.99) 0.78 (0.64-0.87) 0.73 (0.58-0.84) 0.88 (0.76-0.96)
PPV 0.95 (0.86-0.99) 0.77 (0.65-0.88) 0.61 (0.44-0.77) 0.79 (0.59-0.92)
NPV 0.98 (0.90-1.0) 1.00 (0.92-1.0) 1.00 (0.91-1.0) 1.00 (0.92-1.0)
LR+ 17.36 (6.40-50.60) 4.54 (2.93-7.49) 3.64 (2.44-5.84) 8.33 (4.20-17.80)
LR− 0.02 (0.00-0.096) 0.00 (0.00-0.10) 0.00 (0.00-0.21) 0.00 (0.00-0.17)
Abbreviations: CI, 95 % exact confidence interval; LR+, the positive likelihood ratio; LR−, the negative likelihood ratio; NPP, negative predictive value; PPV, positive
predictive value
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ful as an early predictor of UE motor function that is re-
quired for a daily activity, such as drinking from a glass
after a stroke. The ARAT-2 requires no special equipment,
is quick and easy to use and has potential to contribute
with valuable predictive and clinically useful information.
The original ARAT has good measurement properties [5,
6, 20, 32, 33] and has been frequently used in research, as
well as in clinical practice, in many countries. To adminis-
ter the total ARAT a special test kit is required and the test
is rather time-consuming. To be clinically feasible in an
acute setting, a predictive test should be easy to administer,
include few items, not require any special equipment and
be useful both in severe and moderate/mild impairments.
In the present study the PCA showed that only two
components were needed from the ARAT to capture most
of the variance and it was desirable that two items could
predict the function of patients with mild stroke, as well
as severe stroke. The items’ differences in difficulty were
identified with a Mokken analysis [21] in which similar
differences in difficulty also were shown using Rasch ana-
lysis. This provided further support to our theory of the
items’ ability to detect patients with different severities of
motor function impairment.
This study was aimed to be particularly relevant to clin-
ical practice. Sufficient motor function required for a daily
activity was chosen as an outcome and the different time
points selected were relevant for rehabilitation planning
and outcome assessment. This information can be used for
planning of the content of rehabilitation; i.e. training vs
compensatory strategies as well need for care and assist-
ance. To be able to use the upper extremity in a drinking
task is essential for daily activities, and could therefore be
seen as an important clinical goal, which is also stated in a
consensus document published by stroke survivors, care-
givers and health professionals [2]. The task includes both
reaching and grasping movements which are essential for
upper extremity use, in a functional activity. In this study
we tried to cover both, the need for early evaluation (day 3
and day 10) since the length of stay in hospital is getting
shorter, as well as the need for a later assessment, at
1 month, which can be useful for more impaired patients
who will require a longer period of rehabilitation [34].
The likelihood ratios at day 3 to day 10 were high, indi-
cating the possibility of using the ARAT-2 as a screening
test, to predict the level of motor function required for a
drinking task. However, at the later time points, the likeli-
hood ratios, including broad confidence intervals, indi-
cated that it could be problematic to use the ARAT-2 for
late screening. The positive likelihood ratio increased
when using the assessment undertaken at 1 month (com-
pared to the assessment results from day 3) for prediction
at 12 months, but not sufficiently to indicate high accur-
acy in the general stroke population [25].Some limitations of this study should be noted. Firstly,
the dichotomization of the FMA-UE score reduced the
overall information from the data. Using a cut-off of the
FMA-UE (≥32 points) was, with high sensitivity and spe-
cificity, shown to correspond to the ability to use the
arm to perform a drinking task. Secondly, to calculate
the predictive properties of the ARAT-2, 2-way contin-
gency tables were used due to the limited number of pa-
tients in some of the categories (100 % correct
prediction in some categories). A 2-way contingency
table limits the possibility to adjust for confounding vari-
ables such as age, sex or sensory function. Also the fact
that the ARAT was not used to directly predict the
drinking task is a limitation. Moreover, the present study
had a drop-out of 35 % at the final assessment after
12 months, mainly due to deaths, new strokes or with-
drawal from the study. Other potential reasons for the
remaining drop-outs could be the time point for inclu-
sion close to stroke onset, when consequences of the
stroke still were unclear for the patient; this might have
led to the inclusion of patients who only later realized
their limited ability to participate in the study. Another
reason could be the broad inclusion criteria, which were
intended to capture a total population in a stroke unit
with impaired UEs, facilitating inclusion of different
levels of stroke severity, UE impairment and cognitive
function. This might have led to a higher drop-out rate,
but in contrast, an un-selected population after stroke
with impaired UEs was achieved.
In future studies, the discriminative validity using a
cut-off at FMA-UE score of ≥32 to identify persons that
are able to perform a drinking task needs to be assessed
in another stroke cohort. Similarly, the predictive valid-
ity of ARAT-2 to directly predict a drinking task needs
to be investigated in another independent cohort.Conclusions
The ARAT-2 requires no special equipment, is feasible
in the acute setting, and provides information on the ex-
pected UE function required for a drinking task during
the first year post-stroke. The ARAT-2 has a potential to
be implemented in the acute setting and in the stroke
unit, and it could contribute to the knowledge of a pa-
tient’s probable UE function at later stages.
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